tirzepatide weight loss percent timeline results after 8 months on semaglutide Tirzepatide weight-loss study shows promising
Description
The average rate works out to less than a pound per week
Tirzepatide causes some side effects during the first few weeks and the dose escalation period, such as nausea, vomiting, diarrhea and constipation
tirzepatide's dedicated SURPASS-CVOT cardiovascular outcomes trial is ongoing
Tirzepatide may be an excellent option for individuals with type 2 diabetes who have not achieved adequate glycemic control with other medications
The relationship between dose and results is not linear
